770 related articles for article (PubMed ID: 23331522)
1. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
[TBL] [Abstract][Full Text] [Related]
2. Use of the plasma triglyceride/high-density lipoprotein cholesterol ratio to identify cardiovascular disease in hypertensive subjects.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; Leiva Sisnieguez BC; March CE; Stavile RN; Balbín E; Reaven GM
J Am Soc Hypertens; 2014 Oct; 8(10):724-31. PubMed ID: 25418494
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two surrogate estimates of insulin resistance to predict cardiovascular disease in apparently healthy individuals.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Dulbecco CA; Reaven GM
Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):366-373. PubMed ID: 28254109
[TBL] [Abstract][Full Text] [Related]
4. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
[TBL] [Abstract][Full Text] [Related]
5. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
Persson M; Hedblad B; Nelson JJ; Berglund G
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Disease Risk Assessment: Triglyceride/High-Density Lipoprotein versus Metabolic Syndrome Criteria.
Gharipour M; Sadeghi M; Nezafati P; Dianatkhah M; Sarrafzadegan N
J Res Health Sci; 2019 May; 19(2):e00442. PubMed ID: 31278212
[TBL] [Abstract][Full Text] [Related]
7. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
[TBL] [Abstract][Full Text] [Related]
9. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk.
Salazar MR; Carbajal HA; Espeche WG; Dulbecco CA; Aizpurúa M; Marillet AG; Echeverría RF; Reaven GM
Diab Vasc Dis Res; 2011 Apr; 8(2):109-16. PubMed ID: 21562062
[TBL] [Abstract][Full Text] [Related]
10. Higher serum triglyceride to high-density lipoprotein cholesterol ratio was associated with increased cardiovascular mortality in female patients on peritoneal dialysis.
Wu H; Xiong L; Xu Q; Wu J; Huang R; Guo Q; Mao H; Yu X; Yang X
Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):749-55. PubMed ID: 26084271
[TBL] [Abstract][Full Text] [Related]
11. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
[TBL] [Abstract][Full Text] [Related]
12. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men.
Vega GL; Barlow CE; Grundy SM; Leonard D; DeFina LF
J Investig Med; 2014 Feb; 62(2):345-9. PubMed ID: 24402298
[TBL] [Abstract][Full Text] [Related]
13. Ability of the plasma concentration ratio of triglyceride/high-density lipoprotein cholesterol to identify increased cardio-metabolic risk in an east Asian population.
Sung KC; Reaven G; Kim S
Diabetes Res Clin Pract; 2014 Jul; 105(1):96-101. PubMed ID: 24842244
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study.
Suadicani P; Hein HO; Gyntelberg F
Metab Syndr Relat Disord; 2010 Jun; 8(3):215-22. PubMed ID: 20156073
[TBL] [Abstract][Full Text] [Related]
15. Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients.
Marotta T; Russo BF; Ferrara LA
Obesity (Silver Spring); 2010 Aug; 18(8):1608-13. PubMed ID: 20019684
[TBL] [Abstract][Full Text] [Related]
16. Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trials.
Winkler K; Ablethauser CB; Gimpelewicz C; Bortolini M; Isaacsohn JL
Clin Ther; 2007 Sep; 29(9):1987-2000. PubMed ID: 18035198
[TBL] [Abstract][Full Text] [Related]
17. Comparison of assessment techniques: plasma lipid and lipoproteins related to the metabolic syndrome.
Davy BM; Davy KP
Lipids Health Dis; 2006 Jan; 5():3. PubMed ID: 16448573
[TBL] [Abstract][Full Text] [Related]
18. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
[TBL] [Abstract][Full Text] [Related]
19. The association of non-HDL cholesterol with the presence of metabolic syndrome in North Indian subjects with and without CAD.
Garg PR; Kabita S; Sinha E; Kalla L; Kaur L; Saraswathy KN
Ann Hum Biol; 2013 Jan; 40(1):111-5. PubMed ID: 23198906
[TBL] [Abstract][Full Text] [Related]
20. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
